U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07122180) titled 'Post-Market Clinical Follow-Up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy, Safety, and Glucose Control in Patients With Type 1 and Type 2 Diabetes Mellitus' on Aug. 07.
Brief Summary: Post market Clinical follow-up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy, Safety, and Glucose Control in patients with Type 1 and Type 2 Diabetes Mellitus
Study Start Date: June 04
Study Type: OBSERVATIONAL
Condition:
Type 1 Diabetes and Type 2 Diabetes
Blood Glucose
Intervention:
DEVICE: CT3 Series Continuous Glucose Monitor...